Endocyte (ECYT) Gets WHO, USAN Approval for 'Vintafolide' and 'Etarfolatide' Names on EC145, EC20
Go back to Endocyte (ECYT) Gets WHO, USAN Approval for 'Vintafolide' and 'Etarfolatide' Names on EC145, EC20| ENDOCYTE (NASDAQ: ECYT) | Delayed: 23.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.99 | 52 Week High | $4.89 | |||
| Open | $25.06 | 52 Week Low | $2.62 | |||
| Day High | $23.99 | P/E | N/A | |||
| Day Low | $23.99 | EPS | $-0.44 | |||
| Volume | 0 | |||||

